Cost-Effectiveness of Antiplatelet Agents in Secondary Stroke Prevention: The Limits of Certainty

David B. Matchar, Gregory P. Samsa, Suping Liu
  • Value in Health, September 2005, Elsevier
  • DOI: 10.1111/j.1524-4733.2005.00050.x
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr David Bruce Matchar and Dr David Matchar